I can't read the article it seems to be paywalled, but I don't need to This has less than 1% chance of working IMO. I am surprised they got seed funding even. There is no biologic rationale even - AMH is a marker of egg reserve since it is correlated to follicle and egg numbers. why would it even theoretically work to stave off reproductive senescence? Too bad it is not a billion dollar public company like OVAS - would make a great short as it goes to zero
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.